<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Su Q</submitter><funding>Natural Science Foundation of Guangxi Province</funding><funding>National Natural Science Foundation of China</funding><pagination>61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6347606</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(2)</volume><pubmed_abstract>Coronary microembolization (CME) is a common complication seen during primary percutaneous coronary intervention (pPCI). CME-induced myocardiac inflammation is the primary cause of myocardiac injury. Dysregulated miR-142-3p has been implicated in multiple cardiovascular diseases and is significantly downregulated in CME-induced myocardial injury. However, the role of miR-142-3p in CME-induced myocardial injury is unclear. This study herein built a porcine CME model by infusing microembolization spheres into the left anterior descending branch via a microcatheter, and detected the downregulation of miR-142-3p in the myocardial tissues of CME pigs. Echocardiography, hematoxylin basic fuchsin picric acid (HBFP) staining, and western blotting of NF-κB p65, TNF-α, IL-1β, and IL-6 showed that th</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>The mechanism of miR-142-3p in coronary microembolization-induced myocardiac injury via regulating target gene IRAK-1.</pubmed_title><pmcid>PMC6347606</pmcid><funding_grant_id>2016GXNSFBA380022</funding_grant_id><funding_grant_id>81600283</funding_grant_id><pubmed_authors>Su Q</pubmed_authors><pubmed_authors>Kong B</pubmed_authors><pubmed_authors>Lv X</pubmed_authors><pubmed_authors>Qin Z</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Ye Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>The mechanism of miR-142-3p in coronary microembolization-induced myocardiac injury via regulating target gene IRAK-1.</name><description>Coronary microembolization (CME) is a common complication seen during primary percutaneous coronary intervention (pPCI). CME-induced myocardiac inflammation is the primary cause of myocardiac injury. Dysregulated miR-142-3p has been implicated in multiple cardiovascular diseases and is significantly downregulated in CME-induced myocardial injury. However, the role of miR-142-3p in CME-induced myocardial injury is unclear. This study herein built a porcine CME model by infusing microembolization spheres into the left anterior descending branch via a microcatheter, and detected the downregulation of miR-142-3p in the myocardial tissues of CME pigs. Echocardiography, hematoxylin basic fuchsin picric acid (HBFP) staining, and western blotting of NF-κB p65, TNF-α, IL-1β, and IL-6 showed that th</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-05-29T22:27:58.343Z</modification><creation>2025-05-29T22:27:58.343Z</creation></dates><accession>S-EPMC6347606</accession><cross_references><pubmed>30683933</pubmed><doi>10.1038/s41419-019-1341-7</doi></cross_references></HashMap>